APA (7th ed.) Citation

EG, M., R, G., AH, S., DC, T., MR, C., CK, O., & G, F. (1998). Survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: Ten-year analysis--an intergroup study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 16(11), 3486. https://doi.org/10.1200/JCO.1998.16.11.3486

Chicago Style (17th ed.) Citation

EG, Mansour, Gray R, Shatila AH, Tormey DC, Cooper MR, Osborne CK, and Falkson G. "Survival Advantage of Adjuvant Chemotherapy in High-risk Node-negative Breast Cancer: Ten-year Analysis--an Intergroup Study." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 16, no. 11 (1998): 3486. https://doi.org/10.1200/JCO.1998.16.11.3486.

MLA (9th ed.) Citation

EG, Mansour, et al. "Survival Advantage of Adjuvant Chemotherapy in High-risk Node-negative Breast Cancer: Ten-year Analysis--an Intergroup Study." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 16, no. 11, 1998, p. 3486, https://doi.org/10.1200/JCO.1998.16.11.3486.